Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Impact of Artificial Intelligence on Trainee Polyp Miss Rates

NCT: NCT06676930 · COMPLETED

NCT IDNCT06676930
StatusCOMPLETED
Start Date2024-09-10
Completion2026-09-01
SponsorNorthwestern University (OTHER)
First posted
Last updated

Brief Summary

Based on prior studies, trainee and practicing gastroenterologists miss pre-cancerous polyps (adenomas and serrated polyps) during colonoscopy. The use of computer-aided detection (CADe) systems, a form of artificial intelligence (AI) has been shown to help identify colorectal lesions for practicing gastroenterologists. However, less is known how AI impacts polyp detection for trainees. The investigators are conducting a tandem colonoscopy study wherein a portion of the colon is examined first by the trainee and then the attending physician. For each procedure, randomization will occur which will determine whether or not the trainee will utilize AI for their examination of the colon. At the end of the study, the investigators will determine whether AI helps trainees miss fewer polyps during colonoscopy. The investigators will also conduct interviews with trainees to understand how AI impacts colonoscopy training.

Frequently Asked Questions

What is Impact of Artificial Intelligence on Trainee Polyp Miss Rates?

Impact of Artificial Intelligence on Trainee Polyp Miss Rates is a clinical trial registered under NCT06676930. Current status: COMPLETED.

What is the status of NCT06676930?

The current status of NCT06676930 (Impact of Artificial Intelligence on Trainee Polyp Miss Rates) is: COMPLETED.

When did Impact of Artificial Intelligence on Trainee Polyp Miss Rates start?

Impact of Artificial Intelligence on Trainee Polyp Miss Rates started on 2024-09-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑